SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bone Biologics Corp – ‘10-K’ for 12/31/19

On:  Friday, 3/27/20, at 10:00pm ET   ·   As of:  3/30/20   ·   For:  12/31/19   ·   Accession #:  1493152-20-4977   ·   File #:  0-53078

Previous ‘10-K’:  ‘10-K’ on 3/29/19 for 12/31/18   ·   Next:  ‘10-K’ on 4/15/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/21/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/20  Bone Biologics Corp               10-K       12/31/19   63:5.5M                                   M2 Compliance/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    746K 
 2: EX-4.15     Instrument Defining the Rights of Security Holders  HTML     31K 
 3: EX-10.43    Material Contract                                   HTML     18K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
50: R1          Document and Entity Information                     HTML     57K 
19: R2          Consolidated Balance Sheets                         HTML     83K 
37: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
57: R4          Consolidated Statements of Operations               HTML     63K 
51: R5          Consolidated Statement of Stockholders' Deficit     HTML     86K 
20: R6          Consolidated Statement of Stockholders' Deficit     HTML     20K 
                (Parenthetical)                                                  
38: R7          Consolidated Statements of Cash Flows               HTML     93K 
56: R8          The Company                                         HTML     39K 
52: R9          Summary of Significant Accounting Policies          HTML     55K 
61: R10         Accounts Payable and Accrued Expenses               HTML     24K 
42: R11         Notes Payable - Related Party                       HTML     49K 
27: R12         Stockholders' Deficit                               HTML     47K 
33: R13         Stock-based Compensation                            HTML     56K 
60: R14         Income Taxes                                        HTML     42K 
41: R15         Related Party Transactions                          HTML     22K 
26: R16         Deferred Compensation                               HTML     23K 
32: R17         Commitments and Contingencies                       HTML     36K 
59: R18         Subsequent Events                                   HTML     21K 
43: R19         Summary of Significant Accounting Policies          HTML     88K 
                (Policies)                                                       
16: R20         Summary of Significant Accounting Policies          HTML     25K 
                (Tables)                                                         
36: R21         Accounts Payable and Accrued Expenses (Tables)      HTML     24K 
54: R22         Notes Payable - Related Party (Tables)              HTML     41K 
47: R23         Stockholders' Deficit (Tables)                      HTML     41K 
15: R24         Stock-based Compensation (Tables)                   HTML     57K 
35: R25         Income Taxes (Tables)                               HTML     44K 
53: R26         The Company (Details Narrative)                     HTML     85K 
46: R27         Summary of Significant Accounting Policies          HTML     38K 
                (Details Narrative)                                              
17: R28         Summary of Significant Accounting Policies -        HTML     26K 
                Schedule of Antidilutive Securities Excluded from                
                Computation of Earnings Per Share (Details)                      
34: R29         Accounts Payable and Accrued Expenses - Schedule    HTML     26K 
                of Accounts Payable and Accrued Expenses (Details)               
29: R30         Notes Payable - Related Party (Details Narrative)   HTML    144K 
24: R31         Notes Payable - Related Party - Schedule of Notes   HTML     43K 
                Payable (Details)                                                
44: R32         Stockholders' Deficit (Details Narrative)           HTML    101K 
62: R33         Stockholders' Deficit - Schedule of Warrant         HTML     45K 
                Activity (Details)                                               
30: R34         Stockholders' Deficit - Schedule of Outstanding     HTML     57K 
                Vested and Unexercised Common Stock Warrants                     
                (Details)                                                        
25: R35         Stock-based Compensation (Details Narrative)        HTML     38K 
45: R36         Stock-based Compensation - Schedule of Stock        HTML     53K 
                Option Activity (Details)                                        
63: R37         Stock-based Compensation - Schedule of Outstanding  HTML     54K 
                Stock Options (Details)                                          
31: R38         Stock-based Compensation - Schedule of Assumptions  HTML     41K 
                Using Black-Scholes Option Pricing Model (Details)               
23: R39         Stock-based Compensation - Schedule of Non-vested   HTML     45K 
                Options (Details)                                                
39: R40         Income Taxes (Details Narrative)                    HTML     31K 
21: R41         Income Taxes - Schedule of Provision for Income     HTML     42K 
                Taxes (Details)                                                  
48: R42         Income Taxes - Schedule of Deferred Tax Assets and  HTML     39K 
                Liabilities (Details)                                            
55: R43         Income Taxes - Schedule of Income Tax Effective     HTML     43K 
                Tax Rate (Details)                                               
40: R44         Deferred Compensation (Details Narrative)           HTML     31K 
22: R45         Commitments and Contingencies (Details Narrative)   HTML     47K 
49: R46         Subsequent Events (Details Narrative)               HTML     24K 
28: XML         IDEA XML File -- Filing Summary                      XML    105K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     69K 
 9: EX-101.INS  XBRL Instance -- bblg-20191231                       XML   1.08M 
11: EX-101.CAL  XBRL Calculations -- bblg-20191231_cal               XML    130K 
12: EX-101.DEF  XBRL Definitions -- bblg-20191231_def                XML    460K 
13: EX-101.LAB  XBRL Labels -- bblg-20191231_lab                     XML   1.01M 
14: EX-101.PRE  XBRL Presentations -- bblg-20191231_pre              XML    674K 
10: EX-101.SCH  XBRL Schema -- bblg-20191231                         XSD    184K 
18: ZIP         XBRL Zipped Folder -- 0001493152-20-004977-xbrl      Zip    119K 




        
Filing Submission 0001493152-20-004977 – SGML Text

Original SGML Text submitted by:  M2 Compliance LLC/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 3:51:32.2am ET